Methocarbamol Tablet
NDC Package 25685-240-10

11-digit billing NDC: 25685024010
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Methocarbamol tablets is methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. This formulation utilizes a tablet delivery system. Marketed by Regimed Medical, this product is identified by NDC 25685-240 and is authorized under FDA application ANDA040489.

Identification & Billing

NDC Package Code
25685-240-10
Package Description
100 TABLET in 1 BOTTLE
Product Code
25685-240
11-Digit Billing Format
25685024010

Clinical Specifications

Proprietary Name
Methocarbamol
Non-Proprietary Name
Methocarbamol
Substance Name
Methocarbamol
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
METHOCARBAMOL 500 mg/1
Pharmacologic Class
Usage Information
Methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties.Methocarbamol does not directly relax tense skeletal muscles in man.

Regulatory & Marketing

Labeler Name
Regimed Medical
Product Type
Human Prescription Drug
FDA Application #
ANDA040489
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-15-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 25685-240-10 identifies a specific commercial package of 100 tablet in 1 bottle of Methocarbamol, a human prescription drug labeled by Regimed Medical. This tablet is formulated for oral use and contains methocarbamol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Regimed Medical on October 15, 2026. The current certification is valid through December 31, 2027.

How is this Regimed Medical product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 25685024010. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
25685-240-10
11-Digit CMS (5-4-2)
25685-0240-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.